COVID-19 Webinars

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By May 7, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

You May Also Like

Journal of Drugs in Dermatology JDD Article about From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic ReviewFeatured ArticlesLatest NewsMedical DermFrom the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review
March 10, 2026

From the Vault: Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review

Have you read this JDD review on Th17 pathway defects and chronic mucocutaneous candidiasis? We pulled this one from the JDD vault - a must read article that dates back…
Journal of Drugs in Dermatology JDD Article about From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab MonotherapyAlopeciaCase ReportsFeatured ArticlesHairLatest NewsPediatricsFrom Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy
March 7, 2026

From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy

A pediatric case links dupilumab therapy for atopic dermatitis with sustained hair regrowth in extensive alopecia areata Dive into this recent JDD Case Study A single-patient case report describes a…
Journal of Drugs in Dermatology JDD Article about Exploring the Potential Link Between Minoxidil Use and Rosacea Using A Real-World Data BaseAlopeciaFeatured ArticlesHairLatest NewsWhat Every Dermatologist Should Know About Hair
March 6, 2026

What Every Dermatologist Should Know About Hair

Dive into JDD’s hair resources! You told us you wanted more on hair, so JDD listened. Hair disorders—from everyday androgenetic hair loss to the disruptive, emotionally fraught cases of alopecia…

Leave a Reply